| Date | Form | Description | Docs | XBRL | Pages |
| 03/22/21 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
24 | |
| 03/11/21 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
30 |
| 02/05/21 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
3 | |
| 02/05/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 02/01/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/28/21 | 8-K | Current report filing |
|
2 | |
| 01/07/21 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
28 | |
| 01/07/21 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
77 |
| 12/28/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/28/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Presented at the Rivkin Center & American Association of Cancer Research (AACR) 14th Biennial Ovarian Cancer Research Symposium
Read More...Anixa Biosciences to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Read More...Anixa Biosciences Announces Treatment of First Patient in its Ovarian Cancer CAR-T Clinical Trial
Read More...